Acute flaccid myelitis infectious disease should be considered as a cause when patients presented with neurologic symptoms. A subsequent report described 29 cases of enterovirus D68-associated acute flaccid myelitis in Europe in 2016, noting that "these probably represent only the tip of the iceberg." AFM is diagnosed by examining a patient’s nervous system in combination with reviewing images of the spinal cord. A doctor can examine a patient’s nervous system and the places on the body where he or she has weakness, poor muscle tone, and decreased reflexes. In addition, a doctor can do magnetic resonance imaging to look at a patient’s brain
Myelitis firm diagnosis. Rarely, a biopsy of a mass lesion may become necessary when the cause is uncertain. However, in 15–30% of people with subacute or chronic myelitis, a clear cause is never uncovered. Since each case is different, the following are possible treatments that patients might receive in the management of myelitis. High-dose intravenous methyl-prednisolone for 3–5 days is considered as a standard of care for patients suspected to have acute myelitis, unless there are compelling reasons otherwise. The decision to offer continued steroids or add a new treatment is often based on the clinical course and MRI appearance at